Delta Investment Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Delta Investment Management’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-119,333	Closed	-$6.11M	–	302
2025 Q4	$6.11M	Buy	+119,333	New	+$5.52M	1.06%	25

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

Delta Investment Management's SBIO Position: Q1 2026 in Review

Delta Investment Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026, closing a stake of 119,333 shares — an estimated $6.11M sold.

Delta Investment Management first reported a position in SBIO in Q4 2025 and held it in 1 quarter. The position peaked at $6.11M in Q4 2025. 60 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

Delta Investment Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2026 after selling out during the quarter.
Delta Investment Management sold 119,333 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $6.11M.
Delta Investment Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and held it in 1 quarter.
Delta Investment Management's ALPS Medical Breakthroughs ETF position peaked at $6.11M in Q4 2025.
60 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Delta Investment Management's 13F filing for Q1 2026, filed 13 May 2026.